EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Examining the relationship between inflammatory biomarkers during COVID‐19 hospitalization and subsequent long‐COVID symptoms: A longitudinal and retrospective study

Dominic L Sykes, Christina M Van der Feltz-Cornelis iD, Luke Holdsworth, Simon P Hart, Joseph O'Halloran, Steve Holding, Michael G Crooks

Immunity, Inflammation and Disease · 2023-10 · 11 (10)

DOI: 10.1002/iid3.1052 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Immunity, Inflammation and Disease, online erschienen am 30.10.2023. Verfasst von Dominic L Sykes und 6 weiteren Autor:innen. Beteiligte Einrichtung: Hull York Medical School, Hull, UK. Hauptthemen laut MEDLINE: COVID-19. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Long‐COVID is a heterogeneous condition with a litany of physical and neuropsychiatric presentations and its pathophysiology remains unclear. Little is known about the association between inflammatory biomarkers, such as interleukin‐6 (IL‐6) and C‐reactive protein (CRP) in the acute phase, and persistent symptoms after hospitalization in COVID‐19 patients.

Methods

IL‐6, CRP, troponin‐T, and ferritin were analyzed at admission for all patients with COVID‐19 between September 1, 2020 to January 10, 2021. Survivors were followed up 3‐months following hospital discharge and were asked to report persistent symptoms they experienced. Admission data were retrospectively collected. Independent t ‐tests and Mann–Whitney U tests were performed.

Results

In a sample of 144 patients (62.5% male, mean Age 62 years [SD = 13.6]) followed up 3 months after hospital discharge, the commonest symptoms reported were fatigue (54.2%), breathlessness (52.8%), and sleep disturbance (37.5%). In this sample, admission levels of IL‐6, CRP and ferritin were elevated. However, those reporting myalgia, low mood, and anxiety at follow‐up had lower admission levels of IL‐6 (34.9 vs. 52.0 pg/mL, p = .043), CRP (83 vs. 105 mg/L, p = .048), and ferritin (357 vs. 568 ug/L, p = .01) respectively, compared with those who did not report these symptoms. Multivariate regression analysis showed that these associations were confounded by gender, as female patients had significantly lower levels of IL‐6 and ferritin on admission (29.5 vs. 56.1, p = .03 and 421.5 vs. 589, p = .001, respectively) and were more likely to report myalgia, low mood and anxiety, when compared to males.

Conclusions

Our data demonstrate that female patients present more often with lower levels of inflammatory biomarkers on admission which are subsequently associated with long‐term post‐COVID symptoms, such as myalgia and anxiety, in those discharged from hospital with severe COVID‐19. Further research is needed into the role of serum biomarkers in post‐COVID prognostication.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19HumansMaleFemaleMiddle AgedRetrospective StudiesInterleukin-6Post-Acute COVID-19 SyndromeMyalgiaBiomarkersHospitalizationC-Reactive ProteinFerritins

Stichwörter der Autor:innen

COVID-19biomarkersinterleukin-6long-COVID

Substanzen

Interleukin-6BiomarkersC-Reactive ProteinFerritins

Autor:innen und Institutionen

  • Hull York Medical School, Hull, UK.
  • Department of Health Sciences, University of York, York, UK.
  • Hull York Medical School, York, United Kingdom.
  • Institute of Health Sciences, University College London, London, United Kingdom.
  • Buckinghamshire Healthcare NHS Trust, Aylesbury, United Kingdom.
  • NHS Frimley Health Foundation Trust, Frimley, United Kingdom.

ORCID-Profile: Christina M Van der Feltz-Cornelis

Zitieren

APA

Sykes, D. L., Van der Feltz-Cornelis, C. M., Holdsworth, L., Hart, S. P., O'Halloran, J., Holding, S., & Crooks, M. G. (2023). Examining the relationship between inflammatory biomarkers during COVID‐19 hospitalization and subsequent long‐COVID symptoms: A longitudinal and retrospective study. Immunity, Inflammation and Disease, 11(10). https://doi.org/10.1002/iid3.1052

Vancouver

Sykes DL, Van der Feltz-Cornelis CM, Holdsworth L, Hart SP, O'Halloran J, Holding S, et al. Examining the relationship between inflammatory biomarkers during COVID‐19 hospitalization and subsequent long‐COVID symptoms: A longitudinal and retrospective study. Immunity, Inflammation and Disease. 2023;11(10). doi:10.1002/iid3.1052

BibTeX
@article{Sykes2023,
  author = {Sykes, Dominic L and Van der Feltz-Cornelis, Christina M and Holdsworth, Luke and Hart, Simon P and O'Halloran, Joseph and Holding, Steve and Crooks, Michael G},
  title = {Examining the relationship between inflammatory biomarkers during COVID‐19 hospitalization and subsequent long‐COVID symptoms: A longitudinal and retrospective study},
  journal = {Immunity, Inflammation and Disease},
  year = {2023},
  volume = {11},
  number = {10},
  doi = {10.1002/iid3.1052}
}
Kostenlos starten →